阿尔茨海默氏症疾病的病因学
Can Zhang1,2
1Genetics and Aging Research Unit, McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Boston, MA 02129, USA.
Discovery medicine
|October 9, 2023
概括
阿尔茨海默病 (AD) 研究正在推进,重点关注其复杂的原因和异质性. 了解分子机制和危险因素为开发有效干预措施和治疗这种神经退行性疾病的潜在疗法提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是老年人痴呆的主要原因.
- 尽管已经确定了病理特征,但阿尔茨海默病的确切病因仍然不完全理解.
- 阿尔茨海默病的发病表现出显著的异质性,受遗传和可修改的风险因素的影响.
研究的目的:
- 审查了解阿尔茨海默病 (AD) 机制和病因学的最新进展.
- 提供对导致AD的复杂因素的综合视角.
- 突出发展AD治疗干预措施的进展.
主要方法:
- 对AD的多学科调查的审查.
- 对AD病原体背后的分子机制的分析.
- 检查神经网络异常与AD之间的关联.
主要成果:
- 识别多个与AD相关的基因和可修改的风险因素.
- 在阿尔茨海默病的发病过程中存在复杂异质性的证据.
- 分子发现为翻译干预和临床试验提供了基础.
结论:
- 了解AD的分子基础和风险因素对于开发有效的治疗方法至关重要.
- 多学科的方法对于揭开AD病因是必不可少的.
- 持续的研究有望促进AD的理解和治疗开发.
相关概念视频
Alzheimer's Disease: Overview
506
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
506
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Biological Causes of Schizophrenia
65
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
65
Parkinson's Disease: Overview
587
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
587
Dementia
124
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
124


